Aleksandra Pastrak
Overview
Explore the profile of Aleksandra Pastrak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deal C, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman L, Phillip M, et al.
Ther Adv Endocrinol Metab
. 2024 Nov;
15:20420188241277404.
PMID: 39526285
• The efficacy of weekly injections was no different from that of daily injections to treat children who don't make enough growth to grow adequately. ○ Efficacy refers to how...
2.
Reiter L, Greffrath J, Zidel B, Ostrowski M, Gommerman J, Madhi S, et al.
Sci Rep
. 2024 Mar;
14(1):5365.
PMID: 38438427
In the aftermath of the COVID-19 pandemic, the evolution of the SARS-CoV-2 into a seasonal pathogen along with the emergence of new variants, underscores the need for dynamic and adaptable...
3.
Zadik Z, Zelinska N, Iotova V, Skorodok Y, Malievsky O, Mauras N, et al.
J Pediatr Endocrinol Metab
. 2023 Feb;
36(3):261-269.
PMID: 36732285
Objectives: Somatrogon is a long-acting recombinant human growth hormone (GH) employed as a once-weekly treatment for children with GH deficiency (GHD). A 12-month, phase 2 study of once-weekly somatrogon vs....
4.
Horikawa R, Tanaka T, Hasegawa Y, Yorifuji T, Ng D, Rosenfeld R, et al.
Horm Res Paediatr
. 2022 Apr;
95(3):275-285.
PMID: 35417909
Introduction: Somatrogon is a long-acting recombinant human growth hormone being developed as a once-weekly treatment for children with growth hormone deficiency (GHD). The objective of this phase 3 study (NCT03874013)...
5.
Deal C, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman L, Phillip M, et al.
J Clin Endocrinol Metab
. 2022 Apr;
107(7):e2717-e2728.
PMID: 35405011
Context: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development for once-weekly treatment of children with growth hormone deficiency (GHD). Objective: We aimed to compare the efficacy and...
6.
Bokvist K, Ding Y, Landschulz W, Sinha V, Pastrak A, Belin R
Diabetes Obes Metab
. 2019 Mar;
21(7):1606-1614.
PMID: 30848033
Aim: To determine if a 4-week course of 14 mg weekly GLP-1 agonist LY2428757 combined with 3 mg or 2 mg daily gastrin analogue TT223 (LY+TT223) results in long-term glycaemic...
7.
Liang E, Garzone P, Cedarbaum J, Koller M, Tran T, Xu V, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
2(2):186-94.
PMID: 27121673
ELND005 (scyllo-inositol), an endogenous inositol stereoisomer, is being investigated as an oral treatment for Alzheimer's disease (AD). Pharmacokinetics of ELND005 in plasma, cerebrospinal fluid (CSF), and brain was characterized in...
8.
Nava-Ocampo A, Pastrak A, Cruz T, Koren G
Clin Exp Pharmacol Physiol
. 2005 Feb;
32(1-2):13-8.
PMID: 15730428
1. High doses of vitamin B12 (cyanocobalamin) may be therapeutically effective to treat neurological alterations secondary to a wide range of disease states. The aim of the present study was...